Found: 19
Select item for more details and to access through your institution.
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02221-4
- By:
- Publication type:
- Article
The 6-min walk test as a primary end-point in interstitial lung disease.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 165, p. 1, doi. 10.1183/16000617.0087-2022
- By:
- Publication type:
- Article
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273854
- By:
- Publication type:
- Article
Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 2, p. 181, doi. 10.1007/s41030-022-00187-8
- By:
- Publication type:
- Article
Patients' and Healthcare Professionals' Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 1, p. 93, doi. 10.1007/s41030-020-00111-y
- By:
- Publication type:
- Article
Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden.
- Published in:
- Pulmonary Therapy, 2019, v. 5, n. 1, p. 55, doi. 10.1007/s41030-019-0087-9
- By:
- Publication type:
- Article
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002).
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 59, doi. 10.1007/s41030-018-0053-y
- By:
- Publication type:
- Article
Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 2, p. 1081, doi. 10.1007/s12325-021-02009-w
- By:
- Publication type:
- Article
Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 4040, doi. 10.1007/s12325-021-01790-y
- By:
- Publication type:
- Article
Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss.
- Published in:
- Respiration, 2022, v. 101, n. 2, p. 142, doi. 10.1159/000518855
- By:
- Publication type:
- Article
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Respiration, 2018, v. 96, n. 4, p. 314, doi. 10.1159/000489668
- By:
- Publication type:
- Article
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
- Published in:
- Respiration, 2017, v. 93, n. 6, p. 415, doi. 10.1159/000468546
- By:
- Publication type:
- Article
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-023-02589-x
- By:
- Publication type:
- Article